These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 22032577

  • 1. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM, Maaty A, Kalil FA.
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [Abstract] [Full Text] [Related]

  • 2. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J, Kopeć W, Jakobsche-Policht U, Adamiec R.
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [Abstract] [Full Text] [Related]

  • 3. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M, Abdelaziz A, Abbas A, Mahmoud K, Fathy H, El Mongy S, El-Basyuoni S, Ahmed H, McCoy P.
    Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 5. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E, Soltesz P, Der H, Kocsis Z, Tarr T, Bhattoa H, Shoenfeld Y, Szegedi G.
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [Abstract] [Full Text] [Related]

  • 6. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M, Bodill H, Ahmad Y, Durrington PN, Mackness M, Walker M, Bernstein RM, Bruce IN.
    Circulation; 2004 Jul 27; 110(4):399-404. PubMed ID: 15262847
    [Abstract] [Full Text] [Related]

  • 7. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.
    Mak A, Liu Y, Ho RC.
    J Rheumatol; 2011 Jul 27; 38(7):1296-303. PubMed ID: 21459950
    [Abstract] [Full Text] [Related]

  • 8. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ.
    Intern Med J; 2006 Apr 27; 36(4):237-43. PubMed ID: 16640741
    [Abstract] [Full Text] [Related]

  • 9. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R.
    Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917
    [Abstract] [Full Text] [Related]

  • 10. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS, Gaber EW, Maharem DA, Matrawy KA.
    J Nephrol; 2012 Dec 03; 25(4):541-50. PubMed ID: 21956768
    [Abstract] [Full Text] [Related]

  • 11. Microcirculation as determined by iontophoresis in SLE-patients and controls.
    Anania C, Norman M, Heimburger M, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.
    Lupus; 2012 Jul 03; 21(8):815-20. PubMed ID: 22415927
    [Abstract] [Full Text] [Related]

  • 12. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, Ramirez A, Hidalgo-Tenorio C, Jáimez L, Martín J, Jiménez-Alonso J, Grupo Lupus Virgen de las Nieves.
    J Rheumatol; 2009 Oct 03; 36(10):2204-11. PubMed ID: 19723903
    [Abstract] [Full Text] [Related]

  • 13. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL.
    Immunology; 2006 Feb 03; 117(2):280-6. PubMed ID: 16423064
    [Abstract] [Full Text] [Related]

  • 14. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
    Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dörner T.
    Arthritis Rheum; 2003 May 03; 48(5):1332-42. PubMed ID: 12746906
    [Abstract] [Full Text] [Related]

  • 15. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
    Soep JB, Mietus-Snyder M, Malloy MJ, Witztum JL, von Scheven E.
    Arthritis Rheum; 2004 Jun 15; 51(3):451-7. PubMed ID: 15188333
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar 15; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 17. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, Schiffer M, Haller H, Witte T.
    Ann Rheum Dis; 2009 Oct 15; 68(10):1638-43. PubMed ID: 18930996
    [Abstract] [Full Text] [Related]

  • 18. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S, Vasilescu R.
    Rom J Intern Med; 2004 Oct 15; 42(2):343-54. PubMed ID: 15529625
    [Abstract] [Full Text] [Related]

  • 19. Endothelial function analysis and atherosclerotic risk factors in adolescents with systemic lupus erythematosus.
    Nascif AK, Hilário MO, Terreri MT, Ajzen SA, D'Almeida V, Plavnik FL, de Jesus Christofalo DM.
    Int J Adolesc Med Health; 2007 Oct 15; 19(4):497-505. PubMed ID: 18348424
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Oct 15; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.